by Staff | Mar 31, 2025 | PatentVest Pulse
Highlights $400B+ Market, But Not for Everyone: The U.S. brain-computer interface (BCI) market is real—and enormous. But most of that value will be captured by a small number of companies that move early to secure clinical proof, regulatory alignment, and intellectual...
by Staff | Mar 5, 2025 | PatentVest Pulse
1.0 Summary Data centers have evolved from infrastructure providers to become critical enablers, reflecting the changing landscape of generative AI. The increasing need for computational resources and optimized AI workloads has led to greater competition for...
by Staff | Feb 10, 2025 | Press Releases
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025. Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) — Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) (“Invizyne”), a leading designer of cell-free, enzyme-based biomanufacturing...
by Staff | Jan 29, 2025 | Press Releases
SANTA CLARA, Calif.–(BUSINESS WIRE)– HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has submitted a 510(k) application to the U.S. Food and...
by Staff | Dec 18, 2024 | PatentVest Pulse
Contents Summary Market Landscape Overview Dexcom’s Stelo CGM: Features, Target Market, and Pricing Strategy Significance of Stelo as Dexcom’s First OTC CGM Key Competitors in the CGM Market Summary of the competitive landscape, highlighting market share, pricing...
Recent Comments